ArticleFrontiers in oncology2022

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis.

Adithya Chedere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.